A German company that provides products and services that accelerate drug development and manufacturing is set to acquire the ...

Merck will buy Minneapolis-based Bio-Techne Corp. in a deal worth $11.3 billion. Bio-Techne was under pressure from an ...

Merck KGaA agreed to buy Bio-Techne Corporation for about $11.3 billion to bolster its life-science business, marking the ...

The deal is Merck’s largest since 2015, when it spent $17bn on acquiring Sigma-Aldrich, also a life sciences specialist.

In the past year, Merck KGaA has turned its attention to growing its business in supplies for the life sciences industry. The ...

Shares of U.S. life sciences company Bio-Techne jumped more than +22% in premarket trading on Thursday after Merck KGaA agreed to acquire the company for $73 per share in cash, va ...

Germany's Merck boosts life sciences business with $11 billion bet on Bio-Techne German drugmaker Merck KGaA said on Thursday ‌it would buy U.S. firm Bio-Techne for $11.3 billion, its biggest deal in ...

Detailed price information for Bio-Techne Corp (TECH-Q) from The Globe and Mail including charting and trades.

We’re sorry, we are currently experiencing some issues, please try again later. Our team is working diligently to resolve the issue. Thank you for your patience and ...

While Bio-Techne stock has underperformed the broader market over the past year, analysts remain moderately bullish about its ...

Detailed price information for Bio-Techne Corp (TECH-Q) from The Globe and Mail including charting and trades.